LU83649A1 - Quinolones,leurs procedes de preparation et composition therapeutiques les contenant - Google Patents

Quinolones,leurs procedes de preparation et composition therapeutiques les contenant Download PDF

Info

Publication number
LU83649A1
LU83649A1 LU83649A LU83649A LU83649A1 LU 83649 A1 LU83649 A1 LU 83649A1 LU 83649 A LU83649 A LU 83649A LU 83649 A LU83649 A LU 83649A LU 83649 A1 LU83649 A1 LU 83649A1
Authority
LU
Luxembourg
Prior art keywords
quinolone
methyl
compound
general formula
melting point
Prior art date
Application number
LU83649A
Other languages
English (en)
French (fr)
Inventor
Roy Victor Davies
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of LU83649A1 publication Critical patent/LU83649A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
LU83649A 1980-09-26 1981-09-24 Quinolones,leurs procedes de preparation et composition therapeutiques les contenant LU83649A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26
GB8031106 1980-09-26
GB8031162 1980-09-26
GB8031162 1980-09-26
GB8118879 1981-06-19
GB8119062 1981-06-19
GB8118879 1981-06-19
GB8119062 1981-06-19

Publications (1)

Publication Number Publication Date
LU83649A1 true LU83649A1 (fr) 1983-02-22

Family

ID=27449208

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83649A LU83649A1 (fr) 1980-09-26 1981-09-24 Quinolones,leurs procedes de preparation et composition therapeutiques les contenant

Country Status (25)

Country Link
US (2) US4442109A (el)
AT (1) AT379388B (el)
AU (1) AU549078B2 (el)
BG (2) BG36344A3 (el)
CA (1) CA1146943A (el)
CH (1) CH650254A5 (el)
DD (1) DD201890A5 (el)
DE (1) DE3138121A1 (el)
DK (1) DK152674C (el)
ES (2) ES505786A0 (el)
FI (1) FI812997L (el)
FR (1) FR2491064A1 (el)
GR (1) GR75797B (el)
IE (1) IE51542B1 (el)
IL (1) IL63845A (el)
IT (1) IT1189449B (el)
LU (1) LU83649A1 (el)
NL (1) NL8104394A (el)
NO (1) NO154052C (el)
NZ (1) NZ198414A (el)
PH (1) PH18605A (el)
PT (1) PT73666B (el)
RO (2) RO85318B (el)
SE (1) SE457533B (el)
YU (2) YU230181A (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (en) * 1984-01-13 1990-06-27 The Boots Company PLC Use of quinolones for the manufacture of a composition for the treatment of heart failure.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121725A (en) * 1960-07-18 1964-02-18 Phillips Petroleum Co N-heterocyclic sulfides, sulfoxides, sulfones, and n-oxides of said sulfoxides and sulfones
US3801644A (en) * 1971-08-25 1974-04-02 Warner Lambert Co Substituted-o-hydroxy-omega-(methylsulfinyl)acetophenones and process for producing same
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4302360A (en) * 1980-01-11 1981-11-24 Agency Of Industrial Science & Technology Catalyst for catalytic combustion of hydrogen

Also Published As

Publication number Publication date
CH650254A5 (fr) 1985-07-15
IL63845A (en) 1985-02-28
ES8302662A1 (es) 1982-12-01
NO813263L (no) 1982-03-29
NO154052B (no) 1986-04-01
FR2491064B1 (el) 1984-03-16
US4447435A (en) 1984-05-08
FI812997L (fi) 1982-03-27
IT1189449B (it) 1988-02-04
AT379388B (de) 1985-12-27
DK152674C (da) 1988-08-22
NO154052C (no) 1986-07-16
DK152674B (da) 1988-04-11
BG36344A3 (en) 1984-10-15
FR2491064A1 (fr) 1982-04-02
DD201890A5 (de) 1983-08-17
IT8149370A0 (it) 1981-09-25
RO85318A (ro) 1984-09-29
AU7552481A (en) 1982-04-01
CA1146943A (en) 1983-05-24
GR75797B (el) 1984-08-02
ES514411A0 (es) 1983-05-01
US4442109A (en) 1984-04-10
IE51542B1 (en) 1987-01-07
ATA412181A (de) 1985-05-15
IE812033L (en) 1982-03-02
NZ198414A (en) 1983-11-18
YU230181A (en) 1983-12-31
YU144683A (en) 1983-12-31
RO82014A (ro) 1983-06-01
SE8105689L (sv) 1982-03-27
RO85318B (ro) 1984-10-30
DK424781A (da) 1982-03-27
IL63845A0 (en) 1981-12-31
BG36495A3 (en) 1984-11-15
DE3138121A1 (de) 1982-04-15
RO82014B (ro) 1983-05-30
ES505786A0 (es) 1982-12-01
PT73666B (en) 1982-11-22
NL8104394A (nl) 1982-04-16
SE457533B (sv) 1989-01-09
PT73666A (en) 1981-10-01
AU549078B2 (en) 1986-01-16
ES8306111A1 (es) 1983-05-01
PH18605A (en) 1985-08-21

Similar Documents

Publication Publication Date Title
EP0399856B1 (fr) Pteridin-4 (3H)-ones, procédés de préparation et médicaments les contenant
EP0283390B1 (fr) Dérivés du thiazole actifs sur le système cholinergique, procédé d'obtention et compositions pharmaceutiques en contenant
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
CH644366A5 (fr) Quinolones substituees utiles comme agents therapeutiques et procede pour leur preparation.
EP0611766A1 (fr) Dérivés de 2-amido-thiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament
CH646967A5 (fr) Composes de pyranone et compositions pharmaceutiques les comprenant.
EP0624575A1 (fr) Indoles substitués et les compositions pharmaceutiques qui les contiennent
EP0205362B1 (fr) Dérivés quinolylglycinamides, leur procédé de préparation et leur application thérapeutique en tant que psychotropes
EP0162776B1 (fr) Dérivés hétérocycliques, leurs procédés de préparation,médicaments les contenant, utiles notamment comme inhibiteurs de l'aldose réductase
LU83649A1 (fr) Quinolones,leurs procedes de preparation et composition therapeutiques les contenant
EP0117771B1 (fr) Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique
EP0231709B1 (fr) Nouvelles phényl-naphtyridines fonctionnalisées en position-3, leur procédé de préparation, médicaments les contenant, notamment anti-ulcères
EP0115979A1 (fr) Nouveaux dérivés du 1H,3H-pyrrolo (1,2-c) thiazole leur préparation et les médicaments qui les contiennent
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
EP0196943B1 (fr) Nouveaux dérivés 8-thiotétrahydroquinoléines et leurs sels
EP0062580B1 (fr) Dérivés de l'imidazo(1,2-a)quinoléines
RU2069212C1 (ru) Производные имидазола
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
BE890477A (fr) Quinolones, leurs procedes de preparation et composition therapeutique les contenant
EP0017578B1 (fr) Acides 5-(2-hydroxy-3-thiopropoxy)chromone-2-carboxyliques, leurs sels et esters, procédé de préparation et médicaments
EP0362006A1 (fr) Dérivés de quinoléine, leurs procédés de préparation et les médicaments les contenant
GB2085441A (en) Therapeutic agents
EP0168309B1 (fr) Nouveaux dérivés de l'isoxazoloquinoléinone, procédé et intermédiaires de préparation, application à titre de médicaments, et compositions les renfermant
EP0269841B1 (fr) 1-Hydroxyalkylxanthines, leurs procédés de préparation et médicament les contenant
JPH0425268B2 (el)